Research Study – The Sleep Health in Breast Cancer: Evaluating the Impact on Psychological Wellbeing and Medication Adherence
Researchers at the University of Strathclyde Sleep Research Unit in Glasgow (UK) are running a study to investigate the potential difficulties of taking hormone therapy medication, and better understand physical and emotional wellbeing amongst people diagnosed with breast cancer. Eligible breast cancer patients are invited to participate in the research study.
The aims of the study are to:
- understand why people may find it hard to take hormone therapy medication
- identify potential side effects of cancer treatment
- learn about the well-being of people diagnosed with breast cancer
- support the development of future interventions, for people diagnosed with breast cancer who need to take hormone therapy.
Who can participate?
Anyone who is aged 18 years or older, has ever been diagnosed with breast cancer, and has internet access can take part in the study.
What does the study involve?
An anonymous online survey takes 10-15 minutes to complete. This survey includes demographic questions, questions about breast cancer diagnosis, treatment, aspects of physical and mental health, and hormone therapy adherence (where appropriate).
How to take part in the study?
If you are interested in participating in this survey, please visit here. Participation in the study is voluntary.
For any questions or further information, please contact Sommer Agnew at sommer.agnew.2019@uni.strath.ac.uk
The survey closes on 30 June 2022.
This project has been approved by the University of Strathclyde Ethics Board.
